R

ROME Therapeutics

63 employees

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Health Care

Date founded

2020

Funding rounds raised

Total raised

$77M

from 14 investors over 14 rounds

R

ROME Therapeutics raised $72M on September 12, 2023

Investors: Bristol-Myers Squibb, UK, Sanofi Ventures, GV, Section 32 and Casdin Capital, LLC

R

ROME Therapeutics raised $77M on September 14, 2021

Investors: Sanofi Ventures, Andreessen Horowitz, ARCH Venture Partners, Casdin Capital, LLC, GV and Section 32

R

ROME Therapeutics raised $50M on April 27, 2020

Investors: GV, ARCH Venture Partners and Partners HealthCare

FAQ